Articles
Aromatic L-amino acid decarboxylase deficiency: Overview of clinical features and outcomes
Article first published online: 25 JUL 2003
DOI: 10.1002/ana.10631
Copyright © 2003 American Neurological Association
Issue
1531-8249/asset/cover.gif?v=1&s=685ec69724c5ed4c8847ce939e70ceb45065856f)
Annals of Neurology
Supplement: Pediatric Neurotransmitter Diseases
Volume 54, Issue Supplement 6, pages S49–S55, 2003
Additional Information
How to Cite
Swoboda, K. J., Saul, J. P., McKenna, C. E., Speller, N. B. and Hyland, K. (2003), Aromatic L-amino acid decarboxylase deficiency: Overview of clinical features and outcomes. Ann Neurol., 54: S49–S55. doi: 10.1002/ana.10631
Publication History
- Issue published online: 25 JUL 2003
- Article first published online: 25 JUL 2003
Funded by
- General Clinical Research Center
- University of Utah School of Medicine
- ALADD Foundation
- Abstract
- Article
- References
- Cited By
Abstract
In this paper, we provide a brief update of diagnostic considerations and biochemical phenotype in L-amino acid decarboxylase deficiency. We review clinical features and outcome data in 11 affected patients, including 7 previously unreported cases. All had onset of the characteristic movement disorder by 6 months of age. The phenomenology of the movement disorder is identical to that previously reported, and includes intermittent oculogyric crises and limb dystonia, generalized athetosis, and impaired voluntary movement in all patients. Autonomic dysfunction is characterized by a significant impairment of sympathetic regulation of heart rate and blood pressure, as documented via detailed studies with spectral analysis techniques in two patients. Functional clinical outcomes as a group remain poor, in spite of a variety of attempted treatment interventions, with marked impairment in motor abilities as well as in speech and communication; however, outcome was quite variable from patient to patient and covered a broad spectrum of neurological disability. Much further work remains to identify and refine the best treatment options for patients with L-amino acid decarboxylase deficiency. Ann Neurol 2003;54 (suppl 6):S49–S55

1531-8249/asset/olbannerleft.gif?v=1&s=d36d5ebb3caa1b29d7f078a97c52973b0963daf2)
1531-8249/asset/olbannerright.gif?v=1&s=078041b213f6959d63575a593f880457c45116f0)